Literature DB >> 17449332

Drop-out rates of cancer patients participating in longitudinal RCTs.

Lehlohonolo J Mathibe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17449332     DOI： 10.1016/j.cct.2007.03.006

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN： 1551-7144            Impact factor:   2.226


× No keyword cloud information.
  5 in total

1.  Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial.

Authors:  Whitney Wharton; Laura D Baker; Carey E Gleason; Maritza Dowling; Jodi H Barnet; Sterling Johnson; Cynthia Carlsson; Suzanne Craft; Sanjay Asthana
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 2.  Bringing a humanistic approach to cancer clinical trials.

Authors:  Roberto Jun Arai; Elaine Santana Longo; Maria Helena Sponton; Maria Del Pilar Estevez Diz
Journal:  Ecancermedicalscience       Date:  2017-05-18

3.  Illness perception and sense of well-being in breast cancer patients.

Authors:  Yaelim Lee; Jong-Min Baek; Ye-Won Jeon; Eun-Ok Im
Journal:  Patient Prefer Adherence       Date:  2019-09-16       Impact factor: 2.711

4.  Social inequalities in the participation and activity of children and adolescents with leukemia, brain tumors, and sarcomas (SUPATEEN): a protocol for a multicenter longitudinal prospective observational study.

Authors:  Julia Roick; Reinhard Berner; Toralf Bernig; Bernhard Erdlenbruch; Gabriele Escherich; Jörg Faber; Christoph Klein; Konrad Bochennek; Christian Kratz; Joachim Kühr; Alfred Längler; Holger N Lode; Markus Metzler; Hermann Müller; Dirk Reinhardt; Axel Sauerbrey; Florian Schepper; Wolfram Scheurlen; Dominik Schneider; Georg Christof Schwabe; Matthias Richter
Journal:  BMC Pediatr       Date:  2020-01-31       Impact factor: 2.125

5.  IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain.

Authors:  Mauricio Fernandes; Magdalena Schelotto; Philipp Maximilian Doldi; Giovanna Milani; Abul Andrés Ariza Manzano; Doriam Perera Valdivia; Alexandra Marie Winter Matos; Yasmin Hamdy Abdelrahim; Shaza Ahmed Hamad Bek; Benito K Benitez; Vanessa Luiza Romanelli Tavares; Abdulrahim M Basendwah; Luis Henrique Albuquerque Sousa; Naiara Faria Xavier; Tania Zertuche Maldonado; Sarah Toyomi de Oliveira; Melisa Chaker; Michelle Menon Miyake; Elif Uygur Kucukseymen; Kinza Waqar; Ola M J Alkhozondar; Ricardo Bernardo da Silva; Guilhermo Droppelmann; Antonio Vaz de Macedo; Rui Nakamura; Felipe Fregni
Journal:  F1000Res       Date:  2021-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.